https://orcid.org/0000-0003-2972-5032
References
- Mariorana A, Sabia A, Corsetti T, Dionisi-Vici C. Safety of vaccines administration in hereditary fructose intolerance. Orphanet J Rare Dis. 2020;1(15(1)):274. doi:10.1186/s13023-020-01552-z.
- Gallo G, Mel R, Ros E, Filia A, Ed. Guida alle controindicazioni alle vaccinazioni (aggiornamento 2018). Roma (Italy): Istituto Superiore di Sanità; 2019. (Rapporti ISTISAN 19/3).
- European Medicines Agency. Rotarix product information. Annex I-Summary of product characteristics. Last updated: 2020. https://www.ema.europa.eu/en/documents/product-information/rotarix-epar-product-information_en.pdf
- Tate JE, Simonsen L, Viboud C, Steiner C, Patel MM, Curns AT, Parashar UD. Trends in intussusception hospitalizations among US infants, 1993-2004: implications for monitoring the safety of the new rotavirus vaccination program. Pediatrics. 2008;121(5):e1125–32. doi:10.1542/peds.2007-1590.
- Burnett E, Parashar U, Tate J. Rotavirus vaccines: effectiveness, safety and future directions. Paediatr Drugs. 2018 Jun;20(3):223–33. doi:10.1007/s40272-018-0283-3.
- World Health Organization. Rotavirus vaccines WHO position paper – January 2013. Wkly Epidemiol Rec. 2013 Feb 1;88(5):49–64.
- Demirbas D, Brucker WJ, Berry GT. Inborn errors of metabolism with hepatopathy: metabolism defects of galactose, fructose, and tyrosine. Pediatr Clin North Am. 2018;65(2):337–52. doi:10.1016/j.pcl.2017.11.008.
- Di Dato F, Spadarella S, Puoti MG, Caprio MG, Pagliardini S, Zuppaldi C, Vallone G, Fecarotta S, Esposito G, Iorio R, et al. Daily fructose traces intake and liver injury in children with hereditary fructose intolerance. Nutrients. 2019;7(11(10)):2397. doi:10.3390/nu11102397.
- Li H, Byers HM, Diaz-Kuan A, Vos MB, Hall PL, Tortorelli S, Singh R, Wallenstein MB, Allain M, Dimmock DP, et al. Acute liver failure in neonates with undiagnosed hereditary fructose intolerance due to exposure from widely available infant formulas. Mol Genet Metab. 2018;123(4):428–32. doi:10.1016/j.ymgme.2018.02.016.